{'fraction_non_alphanumeric': 0.018867924528301886, 'fraction_numerical': 0.008385744234800839, 'mean_word_length': 5.732394366197183, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The indomethacin treatment of glomerulonephritis patients with the urinary syndrome].

Immediate results are analyzed of the treatment of 57 glomerulonephritis patients with the urinary syndrome using indomethacin. The treatment proved effective in 65% of patients. It was established that indomethacin had no immunotropic effects in urinary syndrome. Absence of arterial hypertension is not a prognosis-positive factor for treatment of the urinary syndrome with indomethacin.